The Middle East and Africa (MEA) region is at the forefront of a global renewable energy transformation, and leading this ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

This year's Super Bowl commercials were filled with surprises. Here are several relatable ads that stole our attention.

A 17-year-old high jump athlete passed out after he landed on the ground with his head and shoulders first during his event in the Palarong Panlalawigan 2025 at a school in Upi, Maguindanao del Norte.

Sana Biotechnology and Vertex Pharmaceuticals represent the region’s leadership in cell and gene therapy, while Inventprise reflects Washington’s roots in global health and vaccines.

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to $550.00. Andrew Fein has given his Buy rating due ...

A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...

The drug's manufacturer, Vertex Pharmaceuticals, said suzetrigine provides effective relief for moderate to severe pain without the addictive potential of opioids. "Today's approval is a historic ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy ...